Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant

We conducted a retrospective study comparing posttransplant outcomes between myeloma patients receiving conditioning melphalan on day-2 vs day-1 for autologous stem cell transplant. Between January 2017 and December 2018, 201 patients received melphalan on day-2 and 166 on day-1 prior to stem cell i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Bone Marrow Transplant
Autori principali: Al Saleh, Abdullah S., Sidiqi, M. Hasib, Lee, JaeWon, Dispenzieri, Angela, Muchtar, Eli, Buadi, Francis K., Warsame, Rahma, Lacy, Martha Q., Dingli, David, Leung, Nelson, Gonsalves, Wilson I., Kapoor, Prashant, Kourelis, Taxiarchis V., Skaer, Christel A., Wittwer, Sarah K., Wolf, Robert C., Hogan, William J., Kumar, Shaji K., Jacob, Eapen, Gertz, Morie A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606597/
https://ncbi.nlm.nih.gov/pubmed/32358546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-0916-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi